Marie-France Tschudin
Director/Board Member chez AXA
Fortune : 5 M $ au 31/03/2024
Profil
Marie-France Tschudin is an Independent Director at AXA SA and a Director at IMD Scholarship Foundation.
She previously worked as a Director at Novartis Pharmaceuticals UK Ltd.
and the European Federation of Pharmaceutical Industries & Assoc.
She also served as Vice President-Hematology & Oncology at Celgene International SARL from 2014 to 2016.
In addition, she held the position of President at Advanced Accelerator Applications SA in 2019.
Ms. Tschudin has also worked as the Chief Commercial Officer at Novartis AG and Novartis Pharma AG, as well as the President of Novartis Pharma Schweiz AG.
She completed her undergraduate studies at Georgetown University and obtained an MBA from the International Institute for Management Development.
Ms. Tschudin's current job(s) include Independent Director at AXA SA and Director at IMD Scholarship Foundation.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVARTIS AG
0,00% | 31/12/2022 | 52 818 ( 0,00% ) | 5 M $ | 31/03/2024 |
Postes actifs de Marie-France Tschudin
| Sociétés | Poste | Début |
|---|---|---|
| AXA | Director/Board Member | 30/06/2020 |
| IMD Scholarship Foundation | Director/Board Member | - |
Anciens postes connus de Marie-France Tschudin
| Sociétés | Poste | Fin |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 15/09/2023 |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | President | 01/06/2019 |
Celgene International SARL
 Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the private company is based in Boudry, Switzerland. | Corporate Officer/Principal | 01/01/2016 |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | President | - |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Formation de Marie-France Tschudin
| Georgetown University | Undergraduate Degree |
| International Institute for Management Development | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AXA | Finance |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 7 |
|---|---|
Celgene International SARL
Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the private company is based in Boudry, Switzerland. | Health Technology |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
| IMD Scholarship Foundation | |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
| European Federation of Pharmaceutical Industries & Assoc |
